Stephen A Boorjian

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Risk factors and outcomes of urethral recurrence following radical cystectomy
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN, USA
    Eur Urol 60:1266-72. 2011
  2. ncbi Natural history of biochemical recurrence after radical prostatectomy with adjuvant radiation therapy
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, Minnesota Electronic address
    J Urol 188:1761-6. 2012
  3. ncbi A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    Eur Urol 61:664-75. 2012
  4. ncbi Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Eur Urol 59:893-9. 2011
  5. ncbi Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    J Urol 186:1796-802. 2011
  6. ncbi Outcomes following partial nephrectomy by tumor size
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 180:1912-7. 2008
  7. ncbi Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland
    Christopher J Weight
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    Eur Urol 60:458-64. 2011
  8. ncbi Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    Cancer 117:2883-91. 2011
  9. ncbi Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Cancer Res 14:5150-7. 2008
  10. ncbi Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    BJU Int 101:299-304. 2008

Collaborators

Detail Information

Publications72

  1. ncbi Risk factors and outcomes of urethral recurrence following radical cystectomy
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN, USA
    Eur Urol 60:1266-72. 2011
    ..Conflicting data exist regarding predictors of urethral recurrence (UR) following radical cystectomy (RC) as well as variables associated with survival in patients who experience UR...
  2. ncbi Natural history of biochemical recurrence after radical prostatectomy with adjuvant radiation therapy
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, Minnesota Electronic address
    J Urol 188:1761-6. 2012
    ..We evaluated the long-term outcome of patients with biochemical recurrence following radical prostatectomy with adjuvant radiation therapy and determined predictors of systemic progression in these men...
  3. ncbi A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    Eur Urol 61:664-75. 2012
    ..Numerous series have reported cancer control and quality-of-life (QoL) outcomes following treatment with radical prostatectomy (RP)...
  4. ncbi Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Eur Urol 59:893-9. 2011
    ..The natural history of biochemical recurrence (BCR) after radical retropubic prostatectomy (RRP) is variable and does not always translate into systemic progression or prostate cancer (PCa) death...
  5. ncbi Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    J Urol 186:1796-802. 2011
    ..Whether routine surveillance to detect tumor recurrence after radical cystectomy improves patient survival remains in debate. We determined the impact on all cause mortality of symptoms at recurrence after cystectomy...
  6. ncbi Outcomes following partial nephrectomy by tumor size
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 180:1912-7. 2008
    ..We established long-term survival in patients following partial nephrectomy according to tumor size...
  7. ncbi Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland
    Christopher J Weight
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    Eur Urol 60:458-64. 2011
    ..The indications for the removal of the ipsilateral adrenal gland in patients with renal cell carcinoma (RCC) and the long-term outcomes have not been well studied...
  8. ncbi Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    Cancer 117:2883-91. 2011
    ..The long-term survival of patients with high-risk prostate cancer was compared after radical prostatectomy (RRP) and after external beam radiation therapy (EBRT) with or without adjuvant androgen-deprivation therapy (ADT)...
  9. ncbi Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Cancer Res 14:5150-7. 2008
    ..As such, we evaluated the association of B7-H3 expression with clinicopathologic outcomes in patients treated for ccRCC...
  10. ncbi Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    BJU Int 101:299-304. 2008
    ..To investigate whether the clinical and pathological outcomes after radical retropubic prostatectomy (RRP) have changed since the advent of prostate-specific antigen (PSA) testing for patients with Gleason 8-10 cancers...
  11. ncbi Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer
    Sameer A Siddiqui
    Department of Urology, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
    BJU Int 107:383-8. 2011
    ..To determine the impact of adjuvant androgen deprivation therapy (ADT) on survival in patients with seminal vesicle invasion (pT3b) at radical prostatectomy...
  12. ncbi Dynamic prediction of metastases after radical prostatectomy for prostate cancer
    Brant A Inman
    Division of Urology, Duke University Medical Center, Durham, NC, USA
    BJU Int 108:1762-8. 2011
    ..The net result is a dynamic tool that renders clinically relevant predictions that change as the patient's clinical status changes throughout the postoperative course...
  13. ncbi Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers
    Paul L Crispen
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55902, USA
    Cancer 113:450-60. 2008
    ..As such, the authors review the current prognostic tools for predicting disease progression for localized RCC, and detail studies to date that have evaluated various biomarkers in this setting...
  14. ncbi Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era
    Stephen A Boorjian
    Department of Urology and Division of Biostatistics, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 178:864-70; discussion 870-1. 2007
    ..We examined the impact of lymph node metastases on the outcome of patients following radical prostatectomy and investigated prognostic factors that affect survival...
  15. ncbi Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation
    Thomas D Atwell
    Department of Diagnostic Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA
    AJR Am J Roentgenol 200:461-6. 2013
    ..The purpose of this article is to compare the efficacy and complication rates of percutaneous radiofrequency ablation (RFA) and cryoablation in the treatment of renal masses measuring 3.0 cm and smaller...
  16. ncbi Contemporary trends of in-hospital complications and mortality for radical cystectomy
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 110:1163-8. 2012
    ..About 29% and 2% of patients undergoing RC will experience a postoperative complication or die during hospitalisation, respectively...
  17. ncbi Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinoma
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    Cancer 118:4412-20. 2012
    ..The objective of this study was to evaluate the accuracy of the pathologic inclusion criteria from all contemporary adjuvant trials in predicting disease progression (DP) for renal cell carcinoma (RCC)...
  18. ncbi Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 188:51-7. 2012
    ..We performed a systematic review and meta-analysis of partial vs radical nephrectomy for localized renal tumors, considering all cause and cancer specific mortality, and severe chronic kidney disease...
  19. ncbi The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy
    Stephen A Boorjian
    Department of Urology, Health Sciences Research, and Laboratory Medicine and Pathology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 181:95-104; discussion 104. 2009
    ..We investigated the association of Gleason score discordance with postoperative systemic progression and death from prostate cancer...
  20. ncbi Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy
    R Houston Thompson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 179:468-71; discussion 472-3. 2008
    ..We reviewed our surgical experience with small renal tumors, comparing overall survival in patients treated with radical and partial nephrectomy...
  21. ncbi T-cell co-regulatory molecule expression in renal angiomyolipoma and pulmonary lymphangioleiomyomatosis
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 74:1359-64. 2009
    ..AML is a highly vascular tumor that most frequently emanates from the kidney. Events leading to its pathogenesis remain enigmatic and understudied...
  22. ncbi Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases
    Grant Chavin
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    Clin Cancer Res 15:2174-80. 2009
    ..Prostate cancer cells uniformly express the immune cell inhibitory B7-H3 ligand. Enhanced B7-H3 expression correlates with increased disease progression and cancer-specific death after radical prostatectomy (RP)...
  23. ncbi Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study
    Sameer A Siddiqui
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    J Urol 179:1830-7; discussion 1837. 2008
    ..We assessed the impact of the timing of androgen deprivation on disease progression after radical prostatectomy for patients with localized prostate cancer...
  24. ncbi Hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma
    Jay D Raman
    Department of Urology, The New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA
    JSLS 10:432-8. 2006
    ....
  25. ncbi Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass
    Candace F Granberg
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 72:148-52. 2008
    ..The indications and results for venovenous bypass (VVB) versus cardiopulmonary bypass (CPB) were reviewed as well...
  26. ncbi Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy
    Michael L Blute
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 178:440-5; discussion 444. 2007
    ..We describe the indications, technique, complications and outcomes of vena caval interruption during nephrectomy with tumor thrombectomy...
  27. ncbi Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 78:1101-6. 2011
    ..To characterize the incidence and clinicopathologic factors associated with late recurrence after surgical resection for renal cell carcinoma (RCC) because the recurrence patterns >5 years after nephrectomy have been poorly described...
  28. ncbi The effect of Gleason score on the predictive value of prostate-specific antigen doubling time
    Matthew K Tollefson
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 105:1381-5. 2010
    ....
  29. ncbi Survival after complete surgical resection of multiple metastases from renal cell carcinoma
    Angela L Alt
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    Cancer 117:2873-82. 2011
    ..The authors report the survival of patients who underwent complete metastasectomy for multiple RCC metastases...
  30. ncbi Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 180:99-103; discussion 103. 2008
    ..We report our experience with resection of isolated retroperitoneal lymph node recurrence...
  31. ncbi T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin Cancer Res 14:4800-8. 2008
    ..We evaluated expression of the T-cell coregulators B7-H1, B7-H3, and PD-1 in urothelial cell carcinoma (UCC) of the bladder...
  32. ncbi 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer
    Christopher R Mitchell
    Departments of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 110:1709-13. 2012
    ..Our study shows that with long-term follow-up RP provides excellent oncological outcomes even at 20 years. While most men do require a multimodal treatment approach, many men can be managed successfully with RP alone...
  33. ncbi Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors
    Grant D Schmit
    Department of Radiology, Mayo Clinic School of Medicine, Rochester, Minnesota 55905, USA
    J Urol 189:30-5. 2013
    ....
  34. ncbi Functional and oncological outcomes after orthotopic neobladder reconstruction in women
    Candace F Granberg
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 102:1551-5. 2008
    ....
  35. ncbi Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Endocr Relat Cancer 16:123-37. 2009
    ..03). Taken together, our data suggest an important role for AR-associated coactivators in UC and point toward differences in the regulation of AR activity between bladder and prostate cancer cells...
  36. ncbi The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Eur Urol 54:855-63. 2008
    ..The origin of bilateral renal masses has not been definitively established to date. As limited studies on the genetics of bilateral tumors exist, defining the clinical behavior of these lesions remains important...
  37. ncbi A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes
    Christopher J Weight
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 186:1223-8. 2011
    ..However, the reproducibility of scoring has not been rigorously validated across specialty or level of training, nor has it been evaluated with regard to meaningful clinical outcomes...
  38. ncbi Impact of obesity on clinicopathologic outcomes after robot-assisted laparoscopic prostatectomy
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    J Endourol 22:1471-6. 2008
    ..To investigate the impact of body mass index (BMI) on pathologic and functional outcomes after robot-assisted laparoscopic prostatectomy (RALP)...
  39. ncbi Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma
    Bradley C Leibovich
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 183:1309-15. 2010
    ..We examined the significance of histological subtype on progression to distant metastasis and cancer specific death after nephrectomy...
  40. ncbi The role of partial nephrectomy for the management of sporadic renal angiomyolipoma
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    Urology 70:1064-8. 2007
    ..Given the benign nature of these lesions, renal-preserving treatments are favored. We evaluated our experience with nephron-sparing surgery for renal angiomyolipoma...
  41. ncbi Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis
    John J Knoedler
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 188:1115-9. 2012
    ..We evaluated patterns of recurrence and survival among matched patients treated with partial vs radical cystectomy for bladder cancer...
  42. ncbi Prognostic Significance of Measured Depth of Invasion of Urothelial Carcinoma of the Bladder Compared to the 2010 American Joint Committee on Cancer pT2 and pT3 Classifications
    Shabnam Zarei
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
    J Urol 188:1706-11. 2012
    ..We compared the prognostic ability of the current American Joint Committee on Cancer (AJCC) staging system to direct measurement of the depth of tumor invasion into the muscularis propria and perivesical fat...
  43. ncbi Complications following 573 percutaneous renal radiofrequency and cryoablation procedures
    Thomas D Atwell
    Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55902, USA
    J Vasc Interv Radiol 23:48-54. 2012
    ..To review complications related to percutaneous renal tumor ablation...
  44. ncbi The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 187:2011-7. 2012
    ..We describe the incidence of hospital acquired adverse events in radical cystectomy, and characterize its relationship with in-hospital mortality, length of stay and hospitalization costs...
  45. ncbi Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota, USA
    J Urol 179:1354-60; discussion 1360-1. 2008
    ..We externally validated the ability of the risk groups to predict clinical progression, and cancer specific and overall survival following radical prostatectomy, and identify predictors of outcome in patients with high risk disease...
  46. ncbi Disparities in access to hospitals with robotic surgery for patients with prostate cancer undergoing radical prostatectomy
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota Electronic address
    J Urol 189:514-20. 2013
    ..We described population level trends in radical prostatectomy for patients with prostate cancer by hospitals with robotic surgery, and assessed whether socioeconomic disparities exist in access to such hospitals...
  47. ncbi Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis
    Brian J Linder
    Department of Urology, Mayo Clinic, Rochester, Minnesota
    J Urol 189:1670-5. 2013
    ..We evaluated oncological outcomes after radical cystectomy in patients with the nested variant of urothelial carcinoma and compared survival to that in patients with pure urothelial carcinoma of the bladder...
  48. ncbi Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons
    Christopher J Weight
    Department of Urology, Mayo Clinic, Rochester, MN, USA
    BJU Int 111:731-8. 2013
    ..We observe that high-volume renal surgeons have different thresholds of 'technical feasibility'...
  49. ncbi Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota
    J Urol 189:2092-8. 2013
    ..In this context we determined whether quality of life and prediction instruments for prostate cancer have been adopted by radiation oncologists and urologists in the United States...
  50. ncbi The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy
    Brian J Linder
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN, USA
    Eur Urol 63:839-45. 2013
    ....
  51. ncbi The relationship of postoperative complications with in-hospital outcomes and costs after renal surgery for kidney cancer
    Simon P Kim
    Department of Urology, Mayo Clinic
    BJU Int 111:580-8. 2013
    ..Moreover, postoperative complications were associated with higher mortality, length of stay and total costs of hospitalisation...
  52. ncbi Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes
    Ryan M Hegg
    Department of Radiology, Mayo Clinic School of Medicine, Rochester, Minnesota
    J Urol 189:1243-8. 2013
    ..We review our single institution experience with percutaneous cryoablation of renal tumors after partial nephrectomy for technical feasibility, complications and outcomes...
  53. ncbi The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota, USA
    J Urol 188:405-9. 2012
    ..We investigated the clinicopathological outcomes of patients treated with cystectomy for pure urothelial carcinoma vs urothelial carcinoma, and squamous and/or glandular differentiation...
  54. ncbi Advances in robotic prostatectomy
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Urol Rep 9:250-6. 2008
    ....
  55. ncbi The impact of family history on pathological and clinical outcomes in non-syndromic clear cell renal cell carcinoma
    Matthew K Tollefson
    Departments of Urology and Health Sciences Research, Mayo Medical School and Mayo Clinic, Rochester, MN, USA
    BJU Int 106:1638-42. 2010
    ..To investigate the impact of family history on pathological and clinical outcomes after surgery for clear-cell renal cell carcinoma (ccRCC) in patients with non-syndromic disease...
  56. ncbi Surgical management of high risk prostate cancer: the Mayo Clinic experience
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, MN 55905, USA
    Urol Oncol 26:530-2. 2008
    ....
  57. ncbi The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis
    Christopher J Weight
    University of Minnesota, Department of Urology, Minneapolis, MN, USA Electronic address
    Eur Urol 63:1021-7. 2013
    ..Lower urinary tract symptoms (LUTS) are common and have been associated with the subsequent diagnosis of prostate cancer (PCa) in population cohorts...
  58. ncbi Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis
    Jeffrey K Wang
    Department of Urology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    World J Urol 30:801-6. 2012
    ..We sought to report the outcomes of patients with MP bladder cancer treated with radical cystectomy (RC) and compare survival to patients with pure UC of the bladder...
  59. ncbi Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort
    Simon P Kim
    Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 186:1779-85. 2011
    ..We describe national trends in partial and radical nephrectomy using a contemporary, population based cohort...
  60. ncbi Hormone receptor expression in renal angiomyolipoma: clinicopathologic correlation
    Stephen A Boorjian
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 72:927-32. 2008
    ..Therefore, we investigated the expression of the androgen receptor (AR), estrogen receptor subtypes alpha (ERalpha) and beta (ERbeta), progesterone receptor, and the enzyme aromatase in renal AML...
  61. ncbi The impact of clinical stage on prostate cancer survival following radical prostatectomy
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota Electronic address
    J Urol 189:1707-12. 2013
    ..In this study we evaluated the association of clinical stage with death from prostate cancer in men who underwent radical prostatectomy and assessed for changes in its prognostic value over time...
  62. ncbi Renal cell carcinoma: vena caval involvement
    Stephen A Boorjian
    Department of Urology, Mayo Clinic, Rochester, MN 55905, USA
    BJU Int 99:1239-44. 2007
  63. ncbi Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma
    Stephen A Boorjian
    Department of Urology, the Division of Hematology and Medical Oncology, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Immunother 30:655-62. 2007
    ..The addition of weekly ATRA-IV to IFN therapy is feasible and well tolerated, resulting in sustainable increased serum (RA). This regimen demonstrates antitumor activity in metastatic RCC, and suggests ATRA-IV augments IFN therapy...
  64. ncbi Ureteroileal anastomosis with intraluminal visualization: technique and outcomes
    Christopher E Barbieri
    Department of Urology, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York, USA
    Urology 76:1496-500. 2010
    ..We examine the rate of ureteral stricture using this method, and review the literature regarding ureteroenteric anastomotic complications with various techniques...
  65. ncbi Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney
    Christopher R Mitchell
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    J Urol 186:1786-90. 2011
    ..Currently to our knowledge data are lacking on the impact of thermal ablation on renal function preservation. We examined the impact on renal function of partial nephrectomy vs percutaneous ablation in patients with a solitary kidney...
  66. ncbi Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
    Jay D Raman
    Department of Urology, The New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA
    Clin Cancer Res 11:8570-6. 2005
    ..We evaluated EZH2 mRNA and protein expression in bladder specimens from patients and the EZH2 mRNA expression in five bladder cancer cell lines...
  67. ncbi Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease
    Matthew K Tollefson
    Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    World J Urol 30:795-9. 2012
    ..Therefore, we reviewed the long-term outcomes in patients who were downstaged to non-invasive urothelial carcinoma at time of RC...
  68. ncbi Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology
    Jay D Raman
    Department of Urology, The New York-Presbyterian Hospital, Weill Medical College of Cornell University, 525 East 68th Street, New York, NY 10021, USA
    BJU Int 96:1031-5. 2005
    ..Neither the pathology of the UUT tumours nor the method of treatment for the UUT disease was associated with recurrent bladder tumours. Only a history of bladder cancer predicted the development of subsequent bladder tumours...
  69. ncbi Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome
    Daniel A Barocas
    Department of Urology, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York 10021, USA
    Urology 66:1134-9. 2005
    ..Decreased 5alphaR expression was associated with disease progression and cause-specific mortality...
  70. ncbi Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Stephen A Boorjian
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 96:773-6. 2005
    ....
  71. ncbi Carcinosarcoma of the prostate replacing the entire lower genitourinary tract
    Shawn M McGee
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 74:540-1. 2009
    ..Despite the dismal survival associated with prostate carcinosarcoma, palliative surgical extirpation can be successful in patients with debilitating pain...
  72. ncbi Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening
    John P Mulhall
    Department of Urology, Loyola University Medical Center, Maywood, Illinois, USA
    J Urol 171:2350-3. 2004
    ..We also noted a significant association between Peyronie's disease aging, hypertension, diabetes and self-reported erectile dysfunction...